Next PEDro and DiTA updates (September 2022)
The next PEDro and DiTA updates are on 5 September 2022.
The next PEDro and DiTA updates are on 5 September 2022.
Type 2 diabetes is a global public health concern, with increasing incidence and financial burden. Improving glycaemic control (measured by glycated haemoglobin, HbA1c) reduces risks of microvascular complications and cardiovascular disease events. Previous systematic reviews …
Last month we summarised the systematic review by Machado P et al. The review concluded that exercise training for colorectal cancer survivors during chemotherapy reduces cancer-related fatigue compared to non-exercise training usual care, although the …
Welcome to the PEDro World-Wide Journal Club. The purpose of the PEDro World-Wide Journal Club is to encourage the global physiotherapy community to read trials, reviews and guidelines that have important implications for clinical practice. …
Language is an important barrier to accessing and implementing evidence-based physiotherapy in many countries, with English being the dominant language used to publish and disseminate evidence-based research and guidelines. This month the barrier of language …
We are excited to announce that the #PEDroTacklesBarriers to evidence-based physiotherapy campaign launch video is now available in French. Thank you to Élodie Louvion from Société Française de Physiothérapie for translating and recording the video. …
DiTA was last updated on 4 July 2022. DiTA contains 2,366 records. In the 1 August 2022 update you will find: 2,117 reports of primary studies, and 249 reports of systematic reviews. For the latest …
PEDro contains 55,812 records. In the 1 August 2022 update you will find: 42,673 reports of randomised controlled trials (41,839 of these trials have confirmed ratings of methodological quality using the PEDro scale) 12,418 reports …
The next PEDro and DiTA updates are on Monday 1 August 2022.
Colorectal cancer is the third most commonly diagnosed cancer worldwide. Up to half of colorectal cancer survivors report cancer-related fatigue, a debilitating and often long-term symptom impacting health-related quality of life and activity participation. . …